These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10781858

  • 1. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children.
    Qadri F, Wennerâs C, Ahmed F, Asaduzzaman M, Saha D, Albert MJ, Sack RB, Svennerholm A.
    Vaccine; 2000 Jun 01; 18(24):2704-12. PubMed ID: 10781858
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age.
    Qadri F, Ahmed T, Ahmed F, Bradley Sack R, Sack DA, Svennerholm AM.
    Vaccine; 2003 Jun 02; 21(19-20):2394-403. PubMed ID: 12744870
    [Abstract] [Full Text] [Related]

  • 3. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
    Hall ER, Wierzba TF, Ahrén C, Rao MR, Bassily S, Francis W, Girgis FY, Safwat M, Lee YJ, Svennerholm AM, Clemens JD, Savarino SJ.
    Infect Immun; 2001 May 02; 69(5):2853-7. PubMed ID: 11292698
    [Abstract] [Full Text] [Related]

  • 4. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.
    Wennerås C, Svennerholm AM, Ahrén C, Czerkinsky C.
    Infect Immun; 1992 Jul 02; 60(7):2605-11. PubMed ID: 1612730
    [Abstract] [Full Text] [Related]

  • 5. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M, El Mohamady H, Abu-Elyazeed R, Naficy A, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD.
    J Infect Dis; 1999 Jan 02; 179(1):107-14. PubMed ID: 9841829
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine.
    Jertborn M, Ahrén C, Holmgren J, Svennerholm AM.
    Vaccine; 1998 Jan 02; 16(2-3):255-60. PubMed ID: 9607039
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec 02; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
    Akhtar M, Qadri F, Bhuiyan TR, Akter S, Rafique TA, Khan A, Islam LN, Saha A, Svennerholm AM, Lundgren A.
    Vaccine; 2017 Jan 05; 35(2):321-328. PubMed ID: 27916412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
    Qadri F, Akhtar M, Bhuiyan TR, Chowdhury MI, Ahmed T, Rafique TA, Khan A, Rahman SIA, Khanam F, Lundgren A, Wiklund G, Kaim J, Löfstrand M, Carlin N, Bourgeois AL, Maier N, Fix A, Wierzba T, Walker RI, Svennerholm AM.
    Lancet Infect Dis; 2020 Feb 05; 20(2):208-219. PubMed ID: 31757774
    [Abstract] [Full Text] [Related]

  • 15. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
    Svennerholm AM.
    Indian J Med Res; 2011 Feb 05; 133(2):188-96. PubMed ID: 21415493
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.
    Wennerås C, Qadri F, Bardhan PK, Sack RB, Svennerholm AM.
    Infect Immun; 1999 Dec 05; 67(12):6234-41. PubMed ID: 10569732
    [Abstract] [Full Text] [Related]

  • 19. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood.
    Ahrén C, Jertborn M, Svennerholm AM.
    Infect Immun; 1998 Jul 05; 66(7):3311-6. PubMed ID: 9632600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.